Geistlich announces the dramatic expansion of their allograft portfolio – vallos® sets the pace for regeneration

PRINCETON, N.J., March 16, 2023 /PRNewswire/ — Geistlich Pharma North America Inc. is pleased to introduce a growing variety of vallos® allograft configurations to increase treatment flexibility through its partnership with a world leading allograft provider. Geistlich Pharma North…